Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas
Completed
- Conditions
- Syndrome of Obstructive Sleep Apnea and Hypopneas
- Registration Number
- NCT02878629
- Lead Sponsor
- ONIRIS
- Brief Summary
The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 254
Inclusion Criteria
- Patients > 18 years treated with Mandibular Advancement Device Tali® from at least 2 years and at the latest 5 years.
- Patients who agree to participate to the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compliance (no stop of the Mandibular Advancement Device) 2 years or more after the beginning of device
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Long-term compliance predictors mandibular advancement device therapy obstructive sleep apnea
Comparative effectiveness mandibular advancement devices versus CPAP OSA patient reported outcomes
Anatomical phenotypes predicting response oral appliance therapy obstructive sleep apnea hypopnea
Adverse events temporomandibular joint dental changes mandibular advancement device OSA management
Mechanisms action mandibular advancement devices upper airway patency obstructive sleep apnea
Trial Locations
- Locations (1)
Liberal cabinet
🇫🇷Paris, France